Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

Short answer: there’s no reliable, up‑to‑date public list I can give you — and most major U.S. telehealth companies stopped offering compounded GLP‑1 products after the FDA’s warnings. If a telehealth vendor now advertises “compounded” semaglutide/tirzepatide, be very cautious: that practice raises legal, safety, and quality concerns.

What I can do instead — practical next steps and safer alternatives

1. Mainstream telehealth that will safely get you GLP‑1 therapy (FDA‑approved drugs)

• Calibrate — a structured weight‑loss program that works with licensed clinicians and prescribes FDA‑approved GLP‑1 medications (Wegovy/semaglutide) when medically appropriate.
• PlushCare — primary‑care telemedicine; clinicians can evaluate and, when appropriate, prescribe FDA‑approved GLP‑1 agents for diabetes or weight‑management.
• Ro (Roman)/Hims & Hers — these telehealth platforms offer clinician visits and can prescribe GLP‑1 medicines through licensed pharmacies depending on state rules and medical appropriateness.

Why these are better: they prescribe FDA‑approved formulations (known dosage, tested manufacturing, labeled safety information) and they document medical evaluation and monitoring.

1. If you are specifically investigating compounded GLP‑1s (not recommended)

• Expect rapid changes: some independent compounding pharmacies briefly continued to compound GLP‑1 analogues, especially for patients who claim need for alternate formulations. That landscape changed quickly after FDA and state pharmacy board enforcement.
• If you nevertheless consider a compounder, only work with pharmacies that are:
  • Licensed in your state and PCAB‑accredited (Pharmacy Compounding Accreditation Board),
  • Will provide a Certificate of Analysis (COA) or batch testing and sterility/assay documentation,
  • Have a pharmacist you can speak with and written policies for returns and adverse‑event reporting.
• Verify your state pharmacy board’s web site for any warnings or disciplinary actions.

1. Safety and legal points (important)

• The FDA warned that compounding complex biologics or copies of approved GLP‑1 drugs can violate federal law and risks unsafe or ineffective products.
• Compounded injectables carry sterility and dosing risks. You may not get the same efficacy or safety as brand‑name, FDA‑approved drugs.
• Insurance and reimbursement generally won’t cover compounded versions; pharmacies may sell them at high markup.
• Always discuss GLP‑1 therapy with a clinician who can evaluate medical appropriateness, monitor labs, and rule out contraindications.

If you want, I can:

• Help you find telehealth clinics in your state that currently prescribe FDA‑approved GLP‑1s,
• Walk through how to vet a compounding pharmacy step‑by‑step,
• Or summarize the FDA guidance/press releases about compounding GLP‑1 products.

Which of those would you like next?